Sherif M Badawy

Sherif M Badawy serves as Associate Professor in Pediatrics (Hematology, Oncology, and Stem Cell Transplantation) at Northwestern University's Feinberg School of Medicine, affiliated with Ann & Robert H. Lurie Children's Hospital of Chicago, the Center for Health Services & Outcomes Research (CHSOR), and the Northwestern University Clinical and Translational Sciences Institute (NUCATS). His clinical expertise focuses on pediatric chronic hematological conditions including sickle cell disease and thalassemia.

His educational credentials include:

• MD from Zagazig University School of Medicine (2005)
• MS in Pediatrics from Zagazig University School of Medicine (2010)
• MS from Northwestern University Feinberg School of Medicine (2016)
• MBA from Northwestern University Kellogg School of Management (2023)

Dr. Badawy's research centers on health services and outcomes with emphasis on technology-based interventions, particularly mHealth solutions for medication adherence and patient-reported outcomes. His work bridges behavior change methodologies with wireless health devices to improve self-management in chronic hematological conditions, targeting both malignant and non-malignant disorders through innovative implementation science approaches.

His 2025 publications demonstrate consistent focus on mHealth applications for sickle cell disease management, adherence monitoring in leukemia therapies, and outcomes analysis in transplantation medicine, reflecting his dual expertise in pediatric hematology and digital health interventions.

Notable recognitions include:

• British Society of Haematology Travel Award (2023)
• NIH/UCLA Scholarship Award (2021)
• Multiple Outstanding Teacher awards from Feinberg School of Medicine (2020, 2019, 2017)
• Faculty Excellence Scholarship Award (2020)
• Child Advocacy Award from Department of Pediatrics (2018)

Dr. Badawy actively contributes through editorial leadership as Editor-in-Chief of JMIR Pediatrics and Parenting and service on 12 editorial boards, while maintaining significant roles in professional societies including ASH and ASPHO committees focused on sickle cell disease, workforce development, and quality improvement initiatives.

He collaborates through CHSOR and NUCATS research networks, directing studies on technology implementation for patient-centered outcomes in hemoglobinopathies while mentoring junior investigators in clinical research methodology.